CRIHX
Price
$12.84
Change
+$0.03 (+0.23%)
Updated
Dec 26 closing price
Net Assets
390.81M
NLSCX
Price
$18.77
Change
+$0.01 (+0.05%)
Updated
Dec 26 closing price
Net Assets
7.96B
Interact to see
Advertisement

CRIHX vs NLSCX

Header iconCRIHX vs NLSCX Comparison
Open Charts CRIHX vs NLSCXBanner chart's image
CRM Long/Short Opportunities Instl
Price$12.84
Change+$0.03 (+0.23%)
VolumeN/A
Net Assets390.81M
Neuberger Berman Long Short C
Price$18.77
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets7.96B
CRIHX vs NLSCX Comparison Chart in %
View a ticker or compare two or three
VS
CRIHX vs. NLSCX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIHX is a Hold and NLSCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 7.96B vs. CRIHX (391M). CRIHX pays higher dividends than NLSCX: CRIHX (0.95) vs NLSCX (0.00). CRIHX was incepted earlier than NLSCX: CRIHX (9 years) vs NLSCX (14 years). NLSCX (2.43) is less costly to investors than CRIHX (2.02). CRIHX is a more actively managed with annual turnover of: 187.00 vs. NLSCX (48.00). NLSCX has a lower initial minimum investment than CRIHX: NLSCX (1000) vs CRIHX (10000). NLSCX annual gain was more profitable for investors over the last year : 5.21 vs. CRIHX (-1.38). CRIHX (16.77) and NLSCX (16.51) have equivalent 5 years return.
CRIHXNLSCXCRIHX / NLSCX
Total Expense Ratio1.872.4377%
Annual Report Gross Expense Ratio2.022.4383%
Fund Existence9 years14 years-
Gain YTD-0.3886.105-6%
Front LoadN/AN/A-
Min. Initial Investment1000010001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets391M7.96B5%
Annual Yield % from dividends0.950.00-
Returns for 1 year-1.385.21-27%
Returns for 3 years15.9625.7662%
Returns for 5 years16.7716.51102%
Returns for 10 yearsN/A45.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFGBX43.280.01
+0.02%
BlackRock Capital Appreciation K
VPMCX180.67N/A
N/A
Vanguard PRIMECAP Inv
MXMVX14.66N/A
N/A
Empower Mid Cap Value Inv
GRGRX46.89-0.01
-0.02%
Goldman Sachs Equity Income R
RYOIX76.19-0.43
-0.56%
Rydex Biotechnology Inv